 |
Corporate News
21-Jun-24
|
|
|
|
|
|
|
|
|
|
|
|
Lupin allots 43,475 equity shares under ESOP
|
|
|
|
|
|
|
|
Lupin has allotted 43,475 fully paid-up equity shares under ESOP on 21 June 2024. In view of the above, the issued and paid-up capital of the Company has been increased to a 91,18,31,906 consisting of 45,59,15,953 equity shares of a 2/- each.
|
|
|
|
Previous News |
Lupin carves-out its LupinLife Consumer Healthcare
(
Corporate News
-
01-Jul-25
18:39
)
|
|
|
Lupin receives USFDA approval for Loteprednol Etabonate Ophthalmic Gel
(
Corporate News
-
01-Jul-25
18:37
)
|
|
|
Lupin update on transfer of its OTC biz to LUPINLIFE Consumer Healthcare
(
Corporate News
-
30-Jun-25
18:54
)
|
|
|
Lupin launches Prucalopride tablets in U.S. market
(
Hot Pursuit
-
26-Jun-25
13:12
)
|
|
|
Lupin launches Prucalopride Tablets in US market
(
Corporate News
-
26-Jun-25
13:05
)
|
|
|
Lupin receives USFDA approval for generic Prucalopride tablets
(
Hot Pursuit
-
25-Jun-25
13:47
)
|
|
|
Lupin receives USFDA approval for Prucalopride Tablets
(
Corporate News
-
25-Jun-25
13:29
)
|
|
|
Lupin allots 20,653 equity shares under ESOP
(
Corporate News
-
24-Jun-25
19:04
)
|
|
|
Lupin inks licensing deal with Sino Universal pharma for Tiotropium DPI drug in China
(
Hot Pursuit
-
16-Jun-25
11:07
)
|
|
|
Lupin gets USFDA nod for Oxcarbazepine ER tablets
(
Hot Pursuit
-
09-Jun-25
08:23
)
|
|
|
Lupin grants 7,337 stock options
(
Corporate News
-
27-May-25
18:42
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|